Prof. Yuval Ebenstein
Yuval Ebenstein studied chemistry and physics at the Hebrew University in Jerusalem, Israel, where he also completed his Ph.D. in physical chemistry with Prof. Uri Banin, studying the photophysical properties of individual semiconductor nanocrystal quantum dots (QDs).
He then moved to work as a postdoc with Prof. Shimon Weiss at UCLA where he used QDs to light-up individual DNA binding proteins and map them along bacteriophage genomes.
In the summer of 2011 he set-up the NanoBioPhotonix Lab in the department of chemical physics, school of chemistry at Tel Aviv University.
firstname.lastname@example.org | +972-54-3188316 | +972-3-6408901
Dr. Miri Neaman
Miri is a post doc and hematologist in Tel Aviv medical center. Her research field is studying methylation and hydroxy-methylation patterns in Hematological malignancies using microarrays.
Sigal is working on Fluorescent detection and global quantification of epigenetic modifications in various cancer types. In my research I developed a high throughput assay for simultaneous enzymatic labeling of 5mC and 5hmC content using multi-sample array slide allowing sensitive analysis that can potentially be used for medical diagnostics.
Improve resolution and overcome the diffraction limit of light with confocal spinning disk microscope (CSD) and Spectral Image Scanning Microscopy (ISM). Encode color into spatial read-out in the image plane with continuously controlling Spectral-resolution (CoCoS) and combine it with the improved resolution.
Eliran develops a Nanopore long read sequencing model that will identify exclusively synthetic modification marker, that will allow easy detection of any epigenetic modification.
Sivan Fishman (Alumni)
Sivan is a joint student with Prof. Michael Gozin from the organic chemistry department. She works on chemical modification of DNA.
Gil Nifker (Alumni)
Gil is a joint student with Prof. Micha Fridman from the organic chemistry department and works on synthesizing and applying epigenetic modification cofactors for DNA labeling.
Gal Goldner (Alumni)
Gal is working on Using Nanopore sequencing in order to develop a new epigenetic analysis tool for breast cancer genescription here
Dr. Yael Michaeli (Alumni)
Yael is responsible for project management and support of all things "bio".She is also developing new epigenetic analysis tools for single-molecule genome mapping and next generation sequencing.
Dr. Christian Heck (Alumni)
Christian is a postdoc who came from Potsdam University in Germany.
He works on the combination of DNA origami and epigenetic research.
Dr. Tamar Shahal (Alumni)
Tamar is involved in several projects in the lab but focuses mainly on the development and application of high-throughput analysis of 5-hydroxymethylcytosine (5hmC) in genomic DNA.
Dr. Rani Arielly (Alumni)
Rani studied physics and then garduated with Prof. Yoram Selzer, where he studied mulecular junctions.
Rani splits his time between developing new code for data nanalysis and developing new DNA imaging devices.
Amit Shwartz (Alumni)
Recent studies have found an association between reduced 5hmc levels and various cancer types. We set forward to test this association by quantifying
5-Hydroxymethylcytosine (5hmc) in different blood cancer samples and comparing them to healthy controls.
Dr. Michal Levi-Sakin (Alumni)
Michal worked on chemo-enzymatic modifications of DNA for epigenetic studies.
She is now a post doctoral fellow with Prof. Pui Kwok at UCSF
Dr. Yifat Berkov-Zrihen (Alumni)
Yifat graduated from the lab of Prof. Micha Fridman specializing in the organic synthesis. She developed synthetic factors for bioconjugation of epigenetic marks.
Mika is developing a pipeline for pattern analysis of a new and advanced DNA microarray methylation array for different types of cancer, using computational tools and statistical models to analyze large datasets of DNA methylation patterns, identifying differentially methylated regions associated with cancer, and optimizing the pipeline for scalability and reproducibility. The ultimate goal is to gain new insights into the molecular mechanisms of cancer development and progression.